Jan Poolman

15.0k total citations · 1 hit paper
233 papers, 11.6k citations indexed

About

Jan Poolman is a scholar working on Microbiology, Epidemiology and Molecular Biology. According to data from OpenAlex, Jan Poolman has authored 233 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 169 papers in Microbiology, 166 papers in Epidemiology and 35 papers in Molecular Biology. Recurrent topics in Jan Poolman's work include Bacterial Infections and Vaccines (167 papers), Pneumonia and Respiratory Infections (144 papers) and Escherichia coli research studies (29 papers). Jan Poolman is often cited by papers focused on Bacterial Infections and Vaccines (167 papers), Pneumonia and Respiratory Infections (144 papers) and Escherichia coli research studies (29 papers). Jan Poolman collaborates with scholars based in Netherlands, Belgium and United States. Jan Poolman's co-authors include H Abdillahi, Peter van der Ley, H. C. Zanen, Lode Schuerman, W D Zollinger, C. E. Frasch, C C Peeters, Peter Hoogerhout, Roman Prymula and Pavla Kriz and has published in prestigious journals such as The Lancet, JAMA and The Journal of Experimental Medicine.

In The Last Decade

Jan Poolman

230 papers receiving 11.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Serotype Antigens of Neisseria meningitidis and a Proposed Scbemefor Designation of Serotypes

1985 394 citations Jan Poolman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Poolman Netherlands	60	8.0k	8.0k	1.9k	1.3k	1.0k	233	11.6k
Carl E. Frasch United States	51	5.4k 0.7×	5.5k 0.7×	1.8k 1.0×	1.5k 1.1×	1.2k 1.2×	138	9.7k
E. Richard Moxon United Kingdom	63	5.7k 0.7×	5.1k 0.6×	3.5k 1.9×	1.3k 1.0×	1.3k 1.3×	231	11.0k
E C Gotschlich United States	61	6.8k 0.8×	5.3k 0.7×	3.8k 2.0×	1.7k 1.3×	1.4k 1.4×	136	13.2k
Dan M. Granoff United States	55	7.1k 0.9×	6.9k 0.9×	1.1k 0.6×	2.0k 1.5×	445 0.4×	234	9.9k
Mariagrazia Pizza Italy	65	5.4k 0.7×	5.0k 0.6×	2.9k 1.6×	3.6k 2.8×	2.1k 2.0×	246	12.0k
David E. Briles United States	74	5.4k 0.7×	10.0k 1.3×	2.2k 1.2×	4.2k 3.2×	617 0.6×	281	15.5k
E. Richard Moxon United Kingdom	47	3.8k 0.5×	3.1k 0.4×	2.2k 1.2×	548 0.4×	700 0.7×	116	6.7k
Ray Borrow United Kingdom	68	11.4k 1.4×	12.4k 1.6×	1.1k 0.6×	1.6k 1.2×	433 0.4×	378	15.7k
Ulrich Vogel Germany	44	3.2k 0.4×	3.3k 0.4×	2.8k 1.5×	998 0.8×	556 0.5×	224	8.5k
Rachel Schneerson United States	57	3.5k 0.4×	4.2k 0.5×	2.7k 1.5×	1.7k 1.2×	2.0k 2.0×	208	10.3k

Countries citing papers authored by Jan Poolman

Since Specialization

Citations

This map shows the geographic impact of Jan Poolman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Poolman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Poolman more than expected).

Fields of papers citing papers by Jan Poolman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Poolman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Poolman. The network helps show where Jan Poolman may publish in the future.

Co-authorship network of co-authors of Jan Poolman

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Poolman. A scholar is included among the top collaborators of Jan Poolman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Poolman. Jan Poolman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abaza, Nouran, Sergey R. Konstantinov, Javier Ruiz‐Guiñazú, et al.. (2025). Incidence of staphylococcus aureus infections after surgical interventions: a systematic review and meta-analysis. Expert Review of Anti-infective Therapy. 23(10). 1011–1029. 1 indexed citations

Geurtsen, Jeroen, Luis Martínez‐Martínez, Patricia Palacios, et al.. (2025). A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals. Epidemiology and Infection. 153. e109–e109.

Blum, Maxim, Jeroen Geurtsen, Eva Herweijer, et al.. (2025). Epidemiology of invasive Escherichia coli disease in adults in England, 2013–2017. Epidemiology and Infection. 153. e4–e4. 1 indexed citations

Schmidt, Mark A., Maxim Blum, Judy Donald, et al.. (2025). Economic and Disease Burden Associated with Invasive Escherichia coli Disease in the United States. Infectious Diseases and Therapy. 14(3). 569–586.

Fierro, Carlos, Michal Sarnecki, Bart Spiessens, et al.. (2023). IMMUNOGENICITY OUTCOMES OF A RANDOMIZED, MULTICENTER, INTERVENTIONAL, FIRST-IN-HUMAN, PHASE 1/2A STUDY OF VAC52416 (EXPEC10V), A VACCINE CANDIDATE FOR THE PREVENTION OF INVASIVE ESCHERICHIA COLI DISEASE. International Journal of Infectious Diseases. 130. S114–S114. 1 indexed citations

Geurtsen, Jeroen, et al.. (2022). Genomics and pathotypes of the many faces ofEscherichia coli. FEMS Microbiology Reviews. 46(6). 99 indexed citations

Queenan, Anne Marie, David J. Dowling, Kellen C. Faé, et al.. (2018). Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro. Vaccine. 37(1). 80–89. 14 indexed citations

Faé, Kellen C., Jeroen Geurtsen, Martin Schwarzer, et al.. (2015). Bordetella pertussis filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cells. International Journal of Medical Microbiology. 306(1). 38–47. 12 indexed citations

Morel, Sandra, et al.. (2011). Induction of Bordetella pertussis-specific immune memory by DTPa vaccines. Vaccine. 29(18). 3449–3455. 10 indexed citations

10.

Nolan, Terry, Peter Richmond, Helen Marshall, et al.. (2010). Immunogenicity and Safety of an Investigational Combined Haemophilus influenzae Type B-Neisseria meningitidis Serogroups C and Y-Tetanus Toxoid Conjugate Vaccine. The Pediatric Infectious Disease Journal. 30(3). 190–196. 21 indexed citations

11.

Dagan, Ron, Jan Poolman, & Fred Zepp. (2008). Combination vaccines containing DTPa–Hib: impact of IPV and coadministration of CRM197 conjugates. Expert Review of Vaccines. 7(1). 97–115. 49 indexed citations

12.

Nolan, Terry, Stephen B. Lambert, Don Roberton, et al.. (2007). A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Vaccine. 25(51). 8487–8499. 45 indexed citations

13.

Poolman, Jan & Hans O. Hallander. (2007). Acellular pertussis vaccines and the role of pertactin and fimbriae. Expert Review of Vaccines. 6(1). 47–56. 48 indexed citations

14.

Godfroid, Fabrice, et al.. (2004). Diphtheria-tetanus-pertussis (DTP) combination vaccines and evaluation of pertussis immune responses. International Journal of Medical Microbiology. 294(5). 269–276. 15 indexed citations

15.

Hazelzet, Jan A., René Stubenitsky, Edwin van der Voort, et al.. (1999). CARDIOVASCULAR ASPECTS OF EXPERIMENTAL MENINGOCOCCAL SEPSIS IN YOUNG AND OLDER AWAKE PIGLETS. Shock. 12(2). 145–154. 9 indexed citations

16.

Cartwright, Keith, Rhonwen Morris, H. C. Rümke, et al.. (1999). Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins. Vaccine. 17(20-21). 2612–2619. 142 indexed citations

17.

Burns, Drusilla, et al.. (1988). Biochemical Properties of Pertussis Toxin(I. Characterization of Virulence Factors of Bordetella pertussis)(Current Studies on Future Vaccines). 13. 181–185. 1 indexed citations

18.

Poolman, Jan. (1988). Gonococci and meningococci : epidemiology, genetics, immunochemistry, and pathogenesis. Kluwer Academic Publishers eBooks. 1 indexed citations

19.

Saukkonen, Kirsi, H Abdillahi, Jan Poolman, & Maija Leinonen. (1987). Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development. Microbial Pathogenesis. 3(4). 261–267. 113 indexed citations

20.

Poolman, Jan. (1982). Problems in the definition of meningococcal serotypes. FEMS Microbiology Letters. 13(4). 339–348. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact